ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,357Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 1454

$1.4M Total Retail Price of All Prescriptions

Rank: 28 out of 1454

897 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 897 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 897 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 19,340 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 1,234 841 1 3
FUROSEMIDE 1,081 747 2 6
SIMVASTATIN 1,055 722 3 1
HYDROCODONE-ACETAMINOPHEN 1,049 686 S3 4 7
LISINOPRIL 957 663 5 4
METOPROLOL TARTRATE 841 581 6 10
AMLODIPINE BESYLATE 683 566 7 2
METFORMIN HCL 680 400 8 8
POTASSIUM CHLORIDE 631 461 9 15
GABAPENTIN 589 358 10 16
ZOLPIDEM TARTRATE 515 300 11 19
LEVOTHYROXINE SODIUM 458 356 12 5
CARVEDILOL 382 317 13 24
TRAMADOL HCL 359 220 14 20
NEXIUM 327 175 15 23
HYDROCHLOROTHIAZIDE 323 202 16 9
GLIMEPIRIDE 322 205 17 33
DONEPEZIL HCL 306 306 18 29
AZITHROMYCIN 305 189 19 42
METOPROLOL SUCCINATE 296 219 20 13
PRAVASTATIN SODIUM 287 175 21 12
PANTOPRAZOLE SODIUM 284 208 22 31
CLOPIDOGREL 277 213 23 32
CRESTOR 274 171 24 22
CEPHALEXIN 267 169 25 127
METHYLPREDNISOLONE 264 145 26 186
SERTRALINE HCL 234 132 27 26
WARFARIN SODIUM 234 207 27 17
PLAVIX 233 187 29 45
CEFDINIR 229 175 30 182
ATORVASTATIN CALCIUM 221 177 31 11
AMLODIPINE BESYLATE-BENAZEPRIL 218 160 32 65
LOSARTAN POTASSIUM 210 181 33 14
TAMSULOSIN HCL 200 169 34 34
ADVAIR DISKUS 195 150 35 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 194 129 36 27
OXYCODONE-ACETAMINOPHEN 193 146 S2 37 60
SYNTHROID 190 117 38 25
CLOTRIMAZOLE-BETAMETHASONE 181 120 39 166
ATENOLOL 178 130 40 18
NOVOLOG 169 148 41 99
CIPROFLOXACIN HCL 167 125 42 64
ESCITALOPRAM OXALATE 164 75 43 78
ALLOPURINOL 159 114 44 28
PROAIR HFA 156 103 45 56
NAMENDA 151 139 46 48
ISOSORBIDE MONONITRATE ER 144 127 47 46
GLIPIZIDE 144 99 47 62
PROMETHAZINE HCL 142 83 R 49 82
CYCLOBENZAPRINE HCL 141 76 R 50 59
MECLIZINE HCL 141 127 50 132
TRAZODONE HCL 134 66 52 50
BUMETANIDE 133 95 53 149
MELOXICAM 129 84 54 37
SPIRIVA 129 94 54 52
CITALOPRAM HBR 127 109 56 21
AMITRIPTYLINE HCL 115 73 R 57 71
LEVOFLOXACIN 114 79 58 95
AGGRENOX 110 99 59 161
RANITIDINE HCL 109 74 60 43
LANTUS 106 60 61 51
VENTOLIN HFA 104 59 62 112
ENALAPRIL MALEATE 102 62 63 58
FLUOXETINE HCL 102 38 63 72
INSULIN SYRINGE 102 50 63 97
LEVOXYL 98 47 66 84
COLCRYS 96 75 67 116
FLUTICASONE PROPIONATE 95 47 68 30
MIRTAZAPINE 95 77 68 53
LEVEMIR 95 65 68 202
PREDNISONE 94 81 71 36
PHENYTOIN SODIUM EXTENDED 92 50 72 138
POLYETHYLENE GLYCOL 3350 91 49 73 61
CLONIDINE HCL 90 61 74 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 63 75 108
PREMARIN 89 63 R 75 131
KLOR-CON 10 87 41 77 141
DIOVAN 85 85 78 40
COMBIVENT 84 44 79 115
RAMIPRIL 82 65 80 66
AMOXICILLIN 81 38 81 133
SUCRALFATE 81 73 81 227
HYDRALAZINE HCL 81 55 81 67
SYMBICORT 81 60 81 143
FLUCONAZOLE 79 43 85 160
CYMBALTA 78 0 86 55
DIVALPROEX SODIUM 75 62 87 106
RISPERIDONE 73 48 88 86
JANUVIA 72 41 89 77
FENTANYL 72 42 S2 89 104
LANTUS SOLOSTAR 71 41 91 79
TRICOR 70 54 92 134
AMIODARONE HCL 70 70 92 223
HUMALOG 68 49 94 153
DILTIAZEM 24HR CD 68 44 94 76
IBUPROFEN 67 34 96 107
LIPITOR 65 61 97 74
DIGOXIN 64 47 98 70
OXYBUTYNIN CHLORIDE ER 64 36 98 156
ALENDRONATE SODIUM 64 54 98 35
VENLAFAXINE HCL ER 61 52 101 105
BACLOFEN 60 36 102 146
LEXAPRO 60 37 102 205
SPIRONOLACTONE 59 26 104 63
ROPINIROLE HCL 59 32 104 96
CARBIDOPA-LEVODOPA 57 57 106 130
LOSARTAN-HYDROCHLOROTHIAZIDE 55 42 107 38
SINGULAIR 55 32 107 83
QUINAPRIL HCL 54 42 109 101
METOCLOPRAMIDE HCL 52 30 110 121
FAMOTIDINE 52 41 110 88
NITROFURANTOIN 51 50 112 273
LEVEMIR FLEXPEN 51 11 112 171
NASONEX 51 44 112 315
PEN NEEDLE 51 25 112 113
EXELON 51 51 112 135
VESICARE 51 42 112 199
QVAR 50 22 118 293
FINASTERIDE 50 50 118 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.